http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2370269-C2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_601c1203d074153e89f4858f93e5cb66 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-67 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61G10-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61H33-14 |
filingDate | 2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2009-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b06abd7df4f9cd8967f0d6c22a9316d4 |
publicationDate | 2009-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2370269-C2 |
titleOfInvention | Method of malignant tumor treatment and gas composition (versions) for its realisation |
abstract | FIELD: medicine. n SUBSTANCE: inventions relate to medicine, namely to oncology, and can be applied in complex treatment of patients with malignant neoplasms. For this purpose introduction of medications possessing antitumor activity is combined with carrying out barotherapy sessions. For each session of barotherapy pressure 0.3-10 kg/cm 2 and atmosphere gas composition are formed in pressure chamber. Gas composition can include air, inert gas or mixture of inert gases, saturated acyclic hydrocarbon or their mixture, as well as ozone and dioxide or protoxide of nitrogen in different combinations and volume ratios. Barotherapy is realised in 1-5 courses. One course includes 10-30 sessions, 1-2 sessions per day with interval between them 0.5-5.0 days. Duration of each session constitutes 0.5-2.0 hours. Between barotherapy courses intervals of 1-2 months are made. Medications of antitumor activity are introduced on days when barotherapy is carried out 0.5-5.0 hours after carrying out corresponding session. n EFFECT: inventions ensure slowing down of tumor growth and its regression, as well as reduction of metastases due to optimal effect of antitumor medications, introduced against the background of weakening of structure interaction and cell metabolism in tumor tissues, arising as a result of inert gases and acyclic hydrocarbons influence on protein polymer chains in tumor. n 15 cl, 13 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2678927-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2695350-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2713455-C2 |
priorityDate | 2006-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 51.